Myriad Genetics (MYGN) Debt to Equity (2008 - 2026)
Myriad Genetics (MYGN) debt to equity from Jun 30, 2008 to Mar 31, 2026. The current Myriad Genetics (MYGN) debt to equity is 35.66%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Myriad Genetics (MYGN)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 32.58% | +476.84% |
| 2024 | 5.65% | +14.90% |
| 2023 | 4.92% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | -100.00% |
| 2020 | 25.52% | N/A |
| 2020 | 25.52% | +4.41% |
| 2020 | 24.44% | N/A |
| 2020 | 24.44% | +13.97% |
| 2019 | 21.44% | N/A |
| 2019 | 21.44% | +2127.60% |
| 2018 | 0.96% | -92.54% |
| 2017 | 12.90% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2010 | 0.00% | N/A |
| 2009 | 0.00% | N/A |
| 2008 | 0.00% | N/A |
Comparison Myriad Genetics (MYGN) debt to equity with competitors
Myriad Genetics (MYGN) debt to equity is 35.66%.